Industry
Drug Manufacturers - Specialty & Generic
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
Loading...
Open
2.34
Mkt cap
272M
Volume
16K
High
2.44
P/E Ratio
4.73
52-wk high
4.95
Low
2.34
Div yield
N/A
52-wk low
0.50
Portfolio Pulse from
December 03, 2024 | 10:30 pm
Portfolio Pulse from Benzinga Newsdesk
October 10, 2024 | 9:31 pm
Portfolio Pulse from Benzinga Newsdesk
September 18, 2024 | 12:18 pm
Portfolio Pulse from Benzinga Newsdesk
August 26, 2024 | 1:38 pm
Portfolio Pulse from Benzinga Newsdesk
June 28, 2024 | 12:33 pm
Portfolio Pulse from Benzinga Newsdesk
May 20, 2024 | 8:13 pm
Portfolio Pulse from Benzinga Insights
March 11, 2024 | 2:44 pm
Portfolio Pulse from Benzinga Insights
March 04, 2024 | 2:44 pm
Portfolio Pulse from Benzinga Newsdesk
March 04, 2024 | 1:17 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.